Source: Digestive Diseases and Sciences. Unidade: FMRP
Assunto: GASTROENTEROPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOTA, José Maurício S. C. et al. Amifostine (Wr-2721) prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence. Digestive Diseases and Sciences, v. 52, n. 1, p. 119-125, 2007Tradução . . Acesso em: 18 nov. 2024.APA
Mota, J. M. S. C., Soares, P. M. G., Menezes, Á. A. J., Lemos, H. P., Cunha, F. de Q., Brito, G. A. C., et al. (2007). Amifostine (Wr-2721) prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence. Digestive Diseases and Sciences, 52( 1), 119-125.NLM
Mota JMSC, Soares PMG, Menezes ÁAJ, Lemos HP, Cunha F de Q, Brito GAC, Ribeiro RA, Souza MHLP de. Amifostine (Wr-2721) prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence. Digestive Diseases and Sciences. 2007 ; 52( 1): 119-125.[citado 2024 nov. 18 ]Vancouver
Mota JMSC, Soares PMG, Menezes ÁAJ, Lemos HP, Cunha F de Q, Brito GAC, Ribeiro RA, Souza MHLP de. Amifostine (Wr-2721) prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence. Digestive Diseases and Sciences. 2007 ; 52( 1): 119-125.[citado 2024 nov. 18 ]
